Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|December 20, 2025
A pathomics model for predicting response to chemo-immunotherapy in lung squamous cell carcinoma: A multicenter studyDongying Wang, Shuai Mu, Minghui Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2020
Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgeryChanghui Li, Yinchen Shen, Fang Hu, et al.
Computer Methods and Programs in Biomedicine|August 30, 2024
Metadata information and fundus image fusion neural network for hyperuricemia classification in diabetesJin Wei, Yupeng Xu, Hanying Wang, et al.
Translational Lung Cancer Research|November 4, 2021
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapyXin Yu, Jiaqi Li, Lingyun Ye, et al.
Frontiers in Pharmacology|April 18, 2022
Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung CancerAnning Xiong, Wei Nie, Lei Cheng, et al.
Translational Lung Cancer Research|September 12, 2022
A retrospective study for prognostic significance of type II diabetes mellitus and hemoglobin A1c levels in non-small cell lung cancer patients treated with pembrolizumabYinchen Shen, Jiaqi Li, Huiping Qiang, et al.
Prenatal Diagnosis|March 7, 2026
Low-Pass Genome Sequencing Reveals Associations Between Chromosomal Aberrations and Ultrasonographic Anomalies in a Cohort of 19,452 FetusesLijuan Pan, Jiayu Wu, Yi Zhang, et al.
Lipids in Health and Disease|September 30, 2025
Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomicsYuan Qu, Yujuan Liu, Junwei Fang, et al.
Respiratory Research|May 12, 2021
Osimertinib alone as second-line treatment for brain metastases (BM) control may be more limited than for non-BM in advanced NSCLC patients with an acquired EGFR T790M mutationChanghui Li, Wei Nie, Jingdong Guo, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2021
Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgeryAnning Xiong, Changhui Li, Jianlin Xu, et al.
Pageof 8